Paper20737263
Effect of ezetimibe-simvastatine over endothelial dysfunction in dyslipidemic patients: assessment by 13N-ammonia positron emission tomography.
Alexanderson E and 8 others. J Nucl Cardiol, 2010. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Effect of ezetimibe-simvastatine over endothelial dysfunction in dyslipidemic patients: assessment by 13N-ammonia positron emission tomography. Papers, record 20737263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20737263
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of ezetimibe-simvastatine over endothelial dysfunction in dyslipidemic patients: assessment by 13N-ammonia positron emission tomography.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ammonia | Major topic |
| Azetidines | Major topic |
| Dyslipidemias | Major topic |
| Endothelium, Vascular | Major topic |
| Nitrogen Isotopes | Major topic |
| Positron-Emission Tomography | Major topic |
| Simvastatin | Major topic |
| Adenosine | |
| Adolescent | |
| Adult | |
| Aged | |
| Anticholesteremic Agents | |
| Case-Control Studies | |
| Ezetimibe | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Myocardium | |
| Prospective Studies | |
| Risk Factors |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 20963538 | Early insights of cardiac risk and treatment response with quantitative PET monitoring of coronary-specific endothelial dysfunction and myocardial perfusion reserve. | https://conductscience.org/library/papers/20963538 |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15643116 | Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. | J Hypertens | 2005 | https://conductscience.org/library/papers/15643116 | PubMed |
| 2 | 12505224 | Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia. | J Am Coll Cardiol | 2002 | https://conductscience.org/library/papers/12505224 | PubMed |
| 3 | 7674504 | Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. | JAMA | 1995 | https://conductscience.org/library/papers/7674504 | PubMed |
| 4 | 6978059 | Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography. | Am J Cardiol | 1982 | https://conductscience.org/library/papers/6978059 | PubMed |
| 5 | 8653869 | Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. | Circulation | 1996 | https://conductscience.org/library/papers/8653869 | PubMed |
| 6 | 15862426 | Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. | J Am Coll Cardiol | 2005 | https://conductscience.org/library/papers/15862426 | PubMed |
| 7 | 1516170 | Quantification of regional myocardial blood flow using 13N-ammonia and reoriented dynamic positron emission tomographic imaging. | Circulation | 1992 | https://conductscience.org/library/papers/1516170 | PubMed |
| 8 | 18754405 | [Endothelial function assessment by positron emission tomography in patients with hypercholesterolemia]. | Arch Cardiol Mex | 2008 | https://conductscience.org/library/papers/18754405 | PubMed |
| 9 | 8640974 | Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. | Circulation | 1996 | https://conductscience.org/library/papers/8640974 | PubMed |
| 10 | 15007110 | Intensive versus moderate lipid lowering with statins after acute coronary syndromes. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15007110 | PubMed |
| 11 | 9603539 | Prediction of coronary heart disease using risk factor categories. | Circulation | 1998 | https://conductscience.org/library/papers/9603539 | PubMed |
| 12 | 12485966 | Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. | Circulation | 2002 | https://conductscience.org/library/papers/12485966 | PubMed |
| 13 | 7842452 | Role of positron emission tomography in the investigation of human coronary circulatory function. | Cardiovasc Res | 1994 | https://conductscience.org/library/papers/7842452 | PubMed |
| 14 | 8044952 | Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. | Circulation | 1994 | https://conductscience.org/library/papers/8044952 | PubMed |
| 15 | 3773199 | Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). | JAMA | 1986 | https://conductscience.org/library/papers/3773199 | PubMed |
| 16 | 15909736 | [Evaluation of coronary flow by means of PET in the Mexican population without coronary artery disease]. | Arch Cardiol Mex | 2005 | https://conductscience.org/library/papers/15909736 | PubMed |
| 17 | 12423708 | Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. | Am J Cardiol | 2002 | https://conductscience.org/library/papers/12423708 | PubMed |
| 18 | 8149518 | Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium. | Circulation | 1994 | https://conductscience.org/library/papers/8149518 | PubMed |
| 19 | 10872616 | The Framingham Study: ITS 50-year legacy and future promise. | J Atheroscler Thromb | 2000 | https://conductscience.org/library/papers/10872616 | PubMed |
| 20 | 1934373 | Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. | Circulation | 1991 | https://conductscience.org/library/papers/1934373 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38534331 | Low Density Lipoprotein Cholesterol Decreases the Expression of Adenosine A2A Receptor and Lipid Rafts-Protein Flotillin-1: Insights on Cardiovascular Risk of Hypercholesterolemia. | Cells | 2024 | https://conductscience.org/library/papers/38534331 | PubMed |
| 30886968 | Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome. | BMC Rheumatol | 2018 | https://conductscience.org/library/papers/30886968 | PubMed |
| 24116351 | Synthesis and in vivo evaluation of an (18)F-labeled glycoconjugate of PD156707 for imaging ETA receptor expression in thyroid carcinoma by positron emission tomography. | Am J Nucl Med Mol Imaging | 2013 | https://conductscience.org/library/papers/24116351 | PubMed |
| 23764095 | Inflammation, coronary flow reserve, and microvascular dysfunction: moving beyond cardiac syndrome X. | JACC Cardiovasc Imaging | 2013 | https://conductscience.org/library/papers/23764095 | PubMed |
| 22714648 | Non-invasive quantification of coronary vascular dysfunction for diagnosis and management of coronary artery disease. | J Nucl Cardiol | 2012 | https://conductscience.org/library/papers/22714648 | PubMed |
| 20963538 | Early insights of cardiac risk and treatment response with quantitative PET monitoring of coronary-specific endothelial dysfunction and myocardial perfusion reserve. | J Nucl Cardiol | 2010 | https://conductscience.org/library/papers/20963538 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20737263
GET https://conductscience.org/api/papers/v1/20737263/references?page=2